Envizion Medical

Company Overview

Snapshot

Founded in September 2017 by Doron Besser, Envizion Medical operates with 11–50 employees. The company has raised $24.2 million across two funding rounds from Technion Research & Development Foundation. In February 2025, Envizion Medical was acquired by ENvue Medical.

Business overview

ENvizion Medical develops advanced solutions for enteral feeding, focusing on dramatically reducing misguided tube insertions during nasoenteral feeding. Their core product, the FDA-cleared ENvue system, utilizes electromagnetic navigation technology to ensure safe and effective tube placement. This technology is designed for patients in intensive care units, pediatric departments, and nursing homes, serving the healthcare industry by improving patient safety and reducing procedure times and costs.

Strategic signal

In February 2025, NanoVibronix completed the acquisition of ENvue Medical Holdings, which included. This strategic move is intended to enhance NanoVibronix's market position in the medical device sector, particularly in enteral feeding technology, and broaden its commercial platform. This signals a significant consolidation in the medical device market, indicating a growth-positive outlook for the combined entity and potential for expanded market reach for Envizion Medical's technology.

Company Intelligence Q&A

What was a significant recent corporate development for Envizion Medical?

In February 2025, Envizion Medical was acquired by ENvue Medical. This acquisition was part of NanoVibronix's broader strategy to enhance its market position in enteral feeding technology.

Who acquired Envizion Medical's operating assets and intellectual property?

In July 2024, Alpha Capital Anstalt acquired all operating assets and intellectual property of Envizion Medical Ltd., including Envizion Medical Inc., which now operates as a privately held entity.

What was the reported acquisition amount for Envizion Medical by Alpha Capital?

In May 2024, Envizion Medical was acquired by Alpha Capital for $1.5 million. The company had previously raised approximately $24 million from private investors and the Technion Innovation Fund.

Did Envizion Medical secure any significant customer orders recently?

In September 2023, Envizion Medical reported receiving purchase orders totaling $300,000 from Seentaraa Healthcare, with revenues expected to be recognized by the end of that month.

Which major medical center adopted Envizion Medical's ENvue system?

In July 2023, Envizion Medical reported the sale of its ENvue system to the University of Texas Southwestern Medical Center, following a trial period with the system.